Advanced Meningococcal Vaccine in Dubai

The meningococcal vaccine protects against bacterial meningitis and septicemia caused by Neisseria meningitidis. As the leading meningitis vaccine Dubai clinics administer, it guards against life-threatening infection of the brain and spinal cord membranes (meningitis) or bloodstream infection (septicemia) that can progress from initial symptoms to critical illness within 24 hours. Even with treatment, the fatality rate is 10 to 15 percent, and survivors may suffer permanent hearing loss, brain damage, or limb amputation. Vaccination is the most effective prevention strategy and is required for Hajj, Umrah, and many school enrollments.

Yes, Saudi Arabia requires all Hajj and Umrah pilgrims to present a valid meningococcal ACWY vaccination certificate. The MENVEO ACWY vaccine must be administered at least 10 days before arrival in Saudi Arabia, and the certificate is valid for five years. We issue the official vaccination certificate required for visa processing at our clinic. We recommend scheduling your vaccination appointment at least two to three weeks before your planned departure to ensure adequate time for immune response and documentation.

The BEXSERO vaccine targets Meningococcal Group B, which is not covered by MENVEO ACWY. MENVEO ACWY covers four serogroups: A, C, W, and Y. Together, the two vaccines provide protection against all five major disease-causing serogroups. MENVEO ACWY is the standard requirement for Hajj, Umrah, and most travel requirements. As a meningitis B vaccine, BEXSERO is particularly recommended for infants, adolescents, university students, and immunocompromised individuals. Your physician will advise whether you need one or both vaccines based on your age, risk factors, and travel plans.

Yes, both meningococcal vaccines are approved and safe for infants. BEXSERO can be administered from two months of age, with doses at 2, 4, and 12 months for the primary infant series. MENVEO ACWY is typically recommended from 11 to 12 years of age for routine immunization, with earlier administration possible for infants at increased risk. Common side effects in infants include injection site tenderness, irritability, and mild fever, which usually resolve within 48 hours. Paracetamol can be given to manage discomfort if needed.

The number of doses depends on the specific vaccine and your age. MENVEO ACWY requires one dose for most adolescents and adults, with a booster recommended at age 16 if the first dose was given at 11 to 12 years. BEXSERO requires two doses for adolescents and adults, given at least one month apart, and three doses for infants (at 2, 4, and 12 months). Individuals with certain immune deficiencies may require additional doses or more frequent boosters. Our physicians will determine the appropriate schedule for your specific situation.

Meningococcal ACWY vaccination is increasingly required or recommended for school enrollment in Dubai and across the UAE, particularly for students entering secondary school and higher education. Many international schools and universities require proof of meningococcal vaccination as part of their health clearance process. Our clinic issues official vaccination records with clinic stamp and physician signature that are accepted by all educational institutions in Dubai. We recommend checking your school's specific requirements and scheduling vaccination well before enrollment deadlines.

Common side effects of meningococcal vaccines include pain, redness, or swelling at the injection site, mild fever, headache, fatigue, and muscle aches. These reactions are generally mild and resolve within one to three days without treatment. BEXSERO may cause slightly more pronounced injection site reactions compared to MENVEO ACWY. Serious adverse reactions are very rare. All patients are observed for 15 minutes after vaccination to monitor for immediate allergic reactions. Contact our clinic if you experience persistent fever, severe headache, or unusual symptoms after vaccination.

Meningococcal vaccines are not routinely recommended during pregnancy unless the benefit clearly outweighs the potential risk, such as during a meningococcal disease outbreak or for essential travel to a high-risk region. If you are pregnant and require meningococcal vaccination for Hajj or Umrah, consult our physician to discuss the timing and risks. MENVEO ACWY is an inactivated vaccine and may be considered when the exposure risk is significant. Ideally, women planning Hajj or Umrah should receive meningococcal vaccination before becoming pregnant.